Evidence map›Paper›PMID 37581503›Full record

ArticleRadiology2023

Extramural Venous Invasion and Tumor Deposit at Diffusion-weighted MRI in Patients after Neoadjuvant Treatment for Rectal Cancer.

Tae-Hyung Kim, Canan Firat, Hannah M Thompson, Natalie Gangai, Junting Zheng, Marinela Capanu, David D B Bates, Viktoriya Paroder, Julio García-Aguilar, Jinru Shia and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. MRI for Rectal Cancer: Updates and Controversies-AJR. American journal of roentgenology · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Tae-Hyung Kim *From the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0002-0333-8475
Canan Firat *From the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0002-4731-1303
Hannah M ThompsonFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0003-3405-5184
Natalie GangaiFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0003-0603-7165
Junting ZhengFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.
Marinela CapanuFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.
David D B BatesFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.
Viktoriya ParoderFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.
Julio García-AguilarFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0003-2451-0948
Jinru ShiaFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0002-4351-2511
Marc J GollubFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0002-6008-0730
Natally HorvatFrom the Departments of Radiology (T.H.K., N.G., D.D.B.B., V.P., M.J.G., N.H.), Pathology (C.F., J.S.), Surgery (H.M.T., J.G.A.), and Epidemiology and Biostatistics (J.Z., M.C.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.ORCID 0000-0001-8849-5789
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Background Diffusion-weighted (DW) imaging is useful in detecting tumor in the primary tumor bed in locally advanced rectal cancer (LARC) after neoadjuvant therapy, but its value in detecting extramural venous invasion (EMVI) and tumor deposit is not well validated. Purpose To evaluate diagnostic accuracy and association with patient prognosis of viable EMVI and tumor deposit on DW images in patients with LARC after neoadjuvant therapy using whole-mount pathology specimens. Materials and Methods This retrospective study included patients who underwent neoadjuvant therapy and surgery from 2018 to 2021. Innovative five-point Likert scale was used by two radiologists to independently evaluate the likelihood of viable EMVI and tumor deposit on restaging DW MRI scans in four axial quadrants (12 to 3 o'clock, 3 to 6 o'clock, 6 to 9 o'clock, and 9 to 12 o'clock). Diagnostic accuracy was assessed at both the per-quadrant and per-patient level, with whole-mount pathology as the reference standard. Weighted κ values for interreader agreement and Cox regression models for disease-free survival and overall survival analyses were used. Results A total of 117 patients (mean age, 56 years ± 12 [SD]; 70 male, 47 female) were included. Pathologically proven viable EMVI and tumor deposit was detected in 29 of 117 patients (25%) and in 44 of 468 quadrants (9.4%). Per-quadrant analyses showed an area under the receiver operating characteristics curve of 0.75 (95% CI: 0.68, 0.83), with sensitivity and specificity of 55% and 96%, respectively. Good interreader agreement was observed between the radiologists (κ = 0.62). Per-patient analysis showed sensitivity and specificity of 62% and 93%, respectively. The presence of EMVI and tumor deposit on restaging DW MRI scans was associated with worse disease-free survival (hazard ratio [HR], 5.6; 95% CI: 2.4, 13.3) and overall survival (HR, 8.9; 95% CI: 1.6, 48.5). Conclusion DW imaging using the five-point Likert scale showed high specificity and moderate sensitivity in the detection of viable extramural venous invasion and tumor deposits in LARC after neoadjuvant therapy, and its presence on restaging DW MRI scans is associated with worse prognosis. Published under a CC BY 4.0 license.

Indexed as

Neoadjuvant TherapyRectal NeoplasmsDiffusion Magnetic Resonance ImagingExtranodal ExtensionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasm InvasivenessRetrospective Studies

Identifiers

PMID37581503
PMCPMC10478788
OpenAlexW4385827406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.